Related Experiment Video
Updated: Mar 2, 2026
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.8K
PET Molecular Imaging-Directed Biopsy: A Review.
Baowei Fei1,2,3, David M Schuster1,3
11 Department of Radiology and Imaging Sciences, Emory University School of Medicine, 1841 Clifton Rd NE, Atlanta, GA 30329.
AJR. American Journal of Roentgenology
|May 16, 2017
Summary
Positron emission tomography (PET) molecular imaging guides biopsies for diagnosing and staging diseases, particularly cancers. This technique provides cellular and molecular insights, enhancing patient management.
Area of Science:
- Oncology
- Molecular Imaging
- Pathology
Background:
- Molecular imaging, particularly Positron Emission Tomography (PET), offers insights into cellular and molecular processes.
- Biopsy remains a cornerstone for disease diagnosis and staging.
Purpose of the Study:
- To review the applications of PET molecular imaging-directed biopsy across various organs.
- To highlight the role of this technique in managing diverse diseases, with an emphasis on cancers.
Main Methods:
- Literature review of studies employing PET imaging to guide biopsy procedures.
- Analysis of disease management strategies incorporating PET-directed biopsy.
Main Results:
- PET imaging provides valuable metabolic information at cellular and molecular levels.
- PET-directed biopsy is increasingly utilized in clinical practice.
Conclusions:
- PET-directed biopsy is a valuable tool for disease diagnosis and staging.
- The integration of PET molecular imaging enhances the precision of biopsies, improving patient care.
